Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes.
Antimicrob Agents Chemother. 2010 Mar;54(3):1068-74. doi: 10.1128/AAC.00447-09. Epub 2009 Dec 28.
Antimicrob Agents Chemother. 2010.
PMID: 20038625
Free PMC article.
Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients.
Ruslami R, Nijland HM, Alisjahbana B, Parwati I, van Crevel R, Aarnoutse RE.
Ruslami R, et al. Among authors: nijland hm.
Antimicrob Agents Chemother. 2007 Jul;51(7):2546-51. doi: 10.1128/AAC.01550-06. Epub 2007 Apr 23.
Antimicrob Agents Chemother. 2007.
PMID: 17452486
Free PMC article.
Clinical Trial.
Item in Clipboard
Evaluation of high- versus standard-dose rifampin in Indonesian patients with pulmonary tuberculosis.
Ruslami R, Nijland H, Aarnoutse R, Alisjahbana B, Soeroto AY, Ewalds S, van Crevel R.
Ruslami R, et al.
Antimicrob Agents Chemother. 2006 Feb;50(2):822-3. doi: 10.1128/AAC.50.2.822-823.2006.
Antimicrob Agents Chemother. 2006.
PMID: 16436757
Free PMC article.
Clinical Trial.
No abstract available.
Item in Clipboard
Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
Nijland HM, Ruslami R, Suroto AJ, Burger DM, Alisjahbana B, van Crevel R, Aarnoutse RE.
Nijland HM, et al.
Clin Infect Dis. 2007 Oct 15;45(8):1001-7. doi: 10.1086/521894. Epub 2007 Sep 4.
Clin Infect Dis. 2007.
PMID: 17879915
Free article.
Clinical Trial.
Item in Clipboard
Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes.
Nijland HM, Ruslami R, Stalenhoef JE, Nelwan EJ, Alisjahbana B, Nelwan RH, van der Ven AJ, Danusantoso H, Aarnoutse RE, van Crevel R.
Nijland HM, et al.
Clin Infect Dis. 2006 Oct 1;43(7):848-54. doi: 10.1086/507543. Epub 2006 Aug 22.
Clin Infect Dis. 2006.
PMID: 16941365
Free article.
Item in Clipboard
High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets.
Nijland HM, L'homme RF, Rongen GA, van Uden P, van Crevel R, Boeree MJ, Aarnoutse RE, Koopmans PP, Burger DM.
Nijland HM, et al.
AIDS. 2008 May 11;22(8):931-5. doi: 10.1097/QAD.0b013e3282faa71e.
AIDS. 2008.
PMID: 18453852
Clinical Trial.
Item in Clipboard
Clinical experience with the combined use of lopinavir/ritonavir and rifampicin.
L'homme RF, Nijland HM, Gras L, Aarnoutse RE, van Crevel R, Boeree M, Brinkman K, Prins JM, Juttmann JR, Burger DM.
L'homme RF, et al. Among authors: nijland hm.
AIDS. 2009 Apr 27;23(7):863-5. doi: 10.1097/QAD.0b013e328329148e.
AIDS. 2009.
PMID: 19352137
Item in Clipboard
Cite
Cite